Macquarie Downgrades Alibaba Health Information Technology to Underperform From Neutral; Price Target Is HK$3.90
Alibaba Health Information Technology Ltd. Raised to Outperform From Hold by Daiwa Capital Markets
UBS Adjusts Alibaba Health Information Technology's Price Target to HK$4.3 From HK$7.8, Keeps at Neutral
No Data
No Data